reverse phase protein microarray (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
90
Structured Review
Cell Signaling Technology Inc
reverse phase protein microarray
Reverse Phase Protein Microarray, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reverse+phase+protein+microarray/microarray/us09096833-347-6-0
Average 90 stars, based on 1 article reviews
Reverse Phase Protein Microarray, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/reverse+phase+protein+microarray/microarray/us09096833-347-6-0
Average 90 stars, based on 1 article reviews
reverse phase protein microarray - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Phospho-proteomics:Article Title: Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. Article Snippet: Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Obstetrics and Gynecology, University of Tübingen, 72076 Tübingen, Germany, Department of Surgery, University of California San Francisco Medical School, San Francisco, California 94115, Department of Oncological and Surgical Sciences, Unversity of Padua, 35128 Padua, Italy, Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy Microarray:Article Title: Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. Article Snippet: Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia 20110, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Obstetrics and Gynecology, University of Tübingen, 72076 Tübingen, Germany, Department of Surgery, University of California San Francisco Medical School, San Francisco, California 94115, Department of Oncological and Surgical Sciences, Unversity of Padua, 35128 Padua, Italy, Cancer Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, and CRO-IRCCS, National Cancer Institute, 33081 Aviano, Italy Article Title: The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth. Article Snippet: .. Acknowledgments: We would like to thank the Mayo Clinic Hepatobiliary SPORE and the Mayo Center for Cell Signaling in Gastroenterology (C-SiG) for providing the Article Title: Continuous bone morphogenetic protein-2 gradients for concentration effect studies on C2C12 osteogenic fate. Article Snippet: Cells can respond to small changes in a varying concentration of exogenous signaling molecules.. Here we propose the use of continuous surface chemical gradients for the in-depth study of dose-dependent effects on cells.. A continuous surface gradient of bone morphogenetic protein-2 (BMP-2) is presented. Article Title: Methods of treating pre-malignant ductal cancer with autophagy inhibitors Article Snippet: Images were captured with either a Nikon Eclipse Clsi confocal or a Nikon Eclipse TE200 microscope in different channels for LysoTracker Red (psuedo-colored red, 561 nm) and Hoechst 33258 (pseudo-colored blue) using either the 10× or 20× objective. .. Cell signaling pathway mapping by reverse Article Title: Surface-Bound Molecular Gradients for the High-Throughput Screening of Cell Responses Article Snippet: .. For the systematic in vitro study of ligand concentration on cell signaling, the Article Title: Current applications of antibody microarrays Article Snippet: Kinexus Bioinformatics , hiPSC-CMs , KAM-850 , 854 , 25055963. .. Sigma-Aldrich , Breast cancer , other:Article Title: Human lung cell models to study aerosol delivery - considerations for model design and development. Article Snippet: Cell signaling and function have been investigated via microarray after exposure to Article Title: Fibroblast signaling events in response to nanotopography: a gene array study. Article Snippet: When considering the complicated nature of cell/tissue interactions with biomaterials, especially materials with nanometric surface features, observation of changes in one or two selected genes or proteins may not be sufficient.. To get a fuller understanding of the scope of responses effected by nanotopography on cells, many genes need to be surveyed.. Recent developments in molecular biology have lead to the commercial production of microarrays. Concentration Assay:Article Title: Continuous bone morphogenetic protein-2 gradients for concentration effect studies on C2C12 osteogenic fate. Article Snippet: Cells can respond to small changes in a varying concentration of exogenous signaling molecules.. Here we propose the use of continuous surface chemical gradients for the in-depth study of dose-dependent effects on cells.. A continuous surface gradient of bone morphogenetic protein-2 (BMP-2) is presented. Article Title: Surface-Bound Molecular Gradients for the High-Throughput Screening of Cell Responses Article Snippet: .. For the systematic in vitro study of ligand concentration on cell signaling, the In Vitro:Article Title: Surface-Bound Molecular Gradients for the High-Throughput Screening of Cell Responses Article Snippet: .. For the systematic in vitro study of ligand concentration on cell signaling, the |
![A discrete role for the alpha catalytic PI3K isoform in proneural (PN) GSCs. ( A ) Expression z-score data from TCGA (Extended Verhaak) for PIK3CA (left panel), PIK3CB (middle panel) and PIK3CD (right panel) were downloaded from the GBM-BioDP ( http://gbm-biodp.nci.nih.gov/ ) for CL (n = 105), MES (n = 124) and PN (n = 113) subtype GBM from the HT Human Genome U133 (HT_HG-U133A) array and analysed using GraphPad Prism 8. As recent evidence suggests the neural subtype represents excessive contamination with normal brain, it has been excluded from the analysis. Unpaired one-way ANOVA, * p ≤ 0.05; ** p ≤ 0.01; **** p ≤ 0.0001. ( B ) Survival analysis based on the impact of the multi-gene prognostic index for coexpression of PIK3CA and NES (upper panels), PIK3CB and NES (middle panels) or PIK3CD and NES (lower panels) for CL (n = 53, left panels), MES (n = 57, middle panels) and PN (n = 56, right panels) subtype. TCGA gene expression data (Verhaak Core) for PIK3CA and NES , PIK3CB and NES or PIK3CD and NES from the HT_HG-U133A array were used for multigene prognostic index. Figure was generated using the GBM-BioDP software. ( C ) GSC lines JK16, 83Mes, 157PN and AC17PN were analysed by Western blot using antibodies against NF1, p110α and GAPDH. Membrane was stripped and reprobed with an antibody against p110β. Lysates from the same experiment were run in parallel and probed for p110 \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\updelta $$\end{document} δ and GAPDH. ( D ) Reverse-phase protein <t>microarray</t> <t>(RPPA)</t> data from TCGA GBM samples. Boxplots of RPPA analytes for phospho-AKT(Ser 473 ) measured in CL (n = 28), MES (n = 29) and PN (n = 41) samples from the cohort of GBM tumours (Extended Verhaak) that was subjected to RPPA analysis within the TCGA consortium. RPPA data were downloaded from the GBM-BioDP and analysed using GraphPad Prism 8. Unpaired one-way ANOVA: * p ≤ 0.05. ( E ) Survival analysis based on RPPA analysis for phospho-AKT(Ser 473 ) using the Extended Verhaak cohort submitted to the TCGA consortium for CL (n = 28, left panel), MES (n = 29, middle panel) and PN (n = 41, right panel) subtypes. Figure was generated using the GBM-BioDP software. ( F ) GSC lines JK16, 83Mes, 157PN and AC17PN were analysed by Western blot using antibodies against AKT. Membrane was stripped and re-probed for p-AKT(Thr 308 ), then stripped and reprobed for p-AKT(Ser 473 ), then stripped and re-probed for HSP90.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_6588/pmc07736588/pmc07736588__41598_2020_78788_Fig4_HTML.jpg)